Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, Jul 1997, 1607-1608, Vol 41, No. 7
JM Meyer, S Ryu, SL Pendland and LH Danziger
The activity of clarithromycin-14-hydroxyclarithromycin (2:1 ratio) and
bismuth subsalicylate or amoxicillin against Helicobacter pylori was
determined by the checkerboard technique in vitro. Clarithromycin-14-
hydroxyclarithromycin and amoxicillin resulted in additive effects in 7 of
22 isolates, compared to 14 of 22 isolates when bismuth subsalicylate was
substituted for amoxicillin. Synergy was not demonstrated and is probably
not responsible for the clinical success of treatment combinations
containing clarithromycin.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori
College of Pharmacy, University of Illinois, Chicago 60612, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»